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Results: After 24 weeks of therapy, mean reduction of
HBV-DNA level, the percentage of patients with HBV-DNA
lower than 5 log10 copies/ml and the percentage of patients
with HBV-DNA level decrease of more than 2 log10 copies/ml
in group B were signiﬁcantly higher than those in group A
(P < 0.05, respectively). At the end of 24, 48 and 96 weeks,
the patients in group B had higher rates of undetectable
serum HBV-DNA levels and ALT normalization than those in
group A (46% vs 25%, 74% vs 54.2%, 88% vs 70.8%; 52% vs
31.3%, 66% vs 43.8%, 82% vs 62.5%; P < 0.05, respectively).
HBeAg seroconversion rate was signiﬁcant hihger in group B
than those in group A (48% vs 27.1%, P < 0.05). There was no
evidence of adverse effect in patients treated for up to 96
weeks.
Conclusion: Adefovir dipivoxil is an effective treatment
option for nucleoside-naive patients with HBeAg-positive
chronic hepatitis B, especially for those with high serum ALT
levels at baseline. Adefovir dipivoxil treatment through 96
weeks was well tolerated and resulted in continued beneﬁt
for patients with HBeAg-positive chronic hepatitis B.
doi:10.1016/j.ijid.2010.02.2015
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Background: To investigate peripheral T-lymphocyte sub-
population proﬁle and its correlation with HBV precore
region 1896 mutation in chronic HBV-infected (CHI) individ-
uals with normal liver function tests.
Methods: HBV precore region 1896 mutation and distri-
bution of T-lymphocyte subpopulations in peripheral blood
were measured in CHI individuals with normal liver func-
tion tests. HBV markers were detected with ELISA. Serum
HBV DNA load was assessed with quantitative real-time
polymerase chain reaction. The results of peripheral T-cell
subsets were compared among groups based on HBV pre-
core region 1896 mutation status, HBeAg, age, sex and the
quantities of HBV DNA.
Results: CHI individuals with normal liver function tests
had signiﬁcantly decreased CD4+ cells and CD4+/CD8+ ratio,
and increased CD8+ cells compared with unifected controls,
all with P < 0.01. Comparing with HBV precore region non-
mutation group, the patients with precore mutation had
signiﬁcant decreased CD4+ cells and CD4+/CD8+ ratio and
increased CD8+ cells. Univariate analysis showed a simi-
lar pattern of these parameters was signiﬁcantly associated
with presence of serum HBeAg expression and high viral
load, all with P < 0.05 or 0.01. The presence of HBeAg
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xpression carried by the HBV precore region mutation
ositive group were not signiﬁcant different than those
bserved in HBV precore region mutation negative group.
here is a signiﬁcant difference in the quantities of HBV
NA between the HBV precore region mutation positive
roup and negative group. No obvious differences of T-
ell parameters and presence of precore mutation were
bserved among various age groups and sex groups, all with
> 0.05.
Conclusion: T-lymphocyte impaired balance was signiﬁ-
antly associated with HBV precore region mutation in CHI
ndividuals with normal liver function tests. Which with
BeAg expression and the HBV DNA replication affect each
ther and co-result in lower T-cell immune function and
hronic infection persistent status.
oi:10.1016/j.ijid.2010.02.2016
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Background: Brazil has been classiﬁed as high endemic
ountry and HAV vaccine is not implemented in the routine
mmunization calendar. The objectives were to estimate the
revalence of hepatitis A among children and adolescents
y Brazilian regions and household/contextual risk factors
ssociation. This population-based survey was conducted
etween 2004 and 2009. It was a Ministry of Health and
AHO initiative with the Universities and Public laboratories
ocated in the State capitals.
Methods: A stratiﬁed multistage cluster sampling tech-
ique with probability proportional to size was used to
elect around 6400 individuals aged between 5 and 19
ears residents of the State capitals and the Federal Dis-
rict. The sample was stratiﬁed according to age (5—9
nd 10- to 19-years-old) within each region. Individual-
nd household-level data were collected by home inter-
